Can metoprolol be crushed safely. How does the formulation affect crushing metoprolol. What are the risks of crushing extended-release metoprolol. When is it appropriate to split metoprolol tablets. How should metoprolol be administered through feeding tubes.

Understanding Metoprolol: Two Distinct Formulations

Metoprolol, a widely prescribed beta-blocker, comes in two primary formulations: metoprolol tartrate and metoprolol succinate. Each formulation has unique properties that significantly impact how they can be administered, particularly when it comes to crushing or splitting the tablets.

Metoprolol Tartrate: The Immediate-Release Option

Metoprolol tartrate, often sold under the brand name Lopressor, is an immediate-release formulation. This means the medication is designed to release its active ingredients quickly upon ingestion.

• Can be safely crushed without altering its efficacy
• Ideal for patients who have difficulty swallowing whole tablets
• Crushing does not affect the medication’s pharmacokinetics

Metoprolol Succinate: The Extended-Release Variant

Metoprolol succinate, marketed as Toprol XL, is an extended-release formulation. This version is engineered to release the medication gradually over time, providing a more consistent blood level of the drug throughout the day.

• Cannot be crushed due to its extended-release mechanism
• Crushing would destroy the controlled-release pellets
• May be split along the score line, unlike most extended-release medications

The Science Behind Crushing Metoprolol

The ability to crush metoprolol depends on its formulation and the underlying pharmaceutical technology used in its production. Understanding these differences is crucial for proper administration and ensuring the medication’s effectiveness.

Why Metoprolol Tartrate Can Be Crushed

Metoprolol tartrate tablets are designed for immediate release, meaning they dissolve quickly in the stomach. Crushing these tablets simply accelerates this process without compromising the drug’s efficacy or safety profile.

The Unique Structure of Metoprolol Succinate

Metoprolol succinate tablets contain numerous controlled-release pellets evenly distributed throughout the tablet. Each pellet acts as an individual delivery device, releasing the medication slowly over time.

Is crushing metoprolol succinate ever safe? No, crushing metoprolol succinate tablets is never recommended. Doing so would destroy the controlled-release pellets, leading to an immediate release of the entire dose, potentially causing adverse effects and reducing the medication’s long-term efficacy.

Proper Administration Techniques for Metoprolol

Administering metoprolol correctly is essential for its effectiveness and patient safety. Different formulations require different handling techniques.

Guidelines for Metoprolol Tartrate

1. Can be taken whole, crushed, or dissolved in water
2. If crushing, ensure the entire dose is consumed
3. May be taken with or without food

Recommendations for Metoprolol Succinate

1. Should be swallowed whole or split along the score line
2. Never crush or chew the tablet
3. Take with or immediately following a meal

Special Considerations for Patients with Swallowing Difficulties

Patients who have trouble swallowing tablets whole face unique challenges when it comes to taking medications like metoprolol. Healthcare providers must consider alternative administration methods to ensure these patients receive proper treatment.

Options for Metoprolol Tartrate

For patients who cannot swallow metoprolol tartrate tablets whole, crushing the medication offers a viable solution. The crushed tablet can be mixed with a small amount of soft food, such as applesauce, or dissolved in water.

Alternatives for Metoprolol Succinate

Patients who cannot swallow metoprolol succinate tablets whole have fewer options. While the tablets can be split, they cannot be crushed. In such cases, healthcare providers might consider:

• Switching to metoprolol tartrate
• Exploring liquid formulations of beta-blockers
• Considering alternative beta-blockers with different formulations

Administering Metoprolol Through Enteral Feeding Tubes

For patients with enteral feeding tubes, administering medications requires special consideration. The choice of metoprolol formulation and the method of administration are critical factors in ensuring proper treatment.

Guidelines for Tube Administration

How should metoprolol be administered through feeding tubes? When using feeding tubes, metoprolol tartrate is the preferred formulation. It can be crushed and mixed with water for administration. Metoprolol succinate should not be used in feeding tubes due to its extended-release properties.

1. Crush metoprolol tartrate tablets finely
2. Mix with 10-15 mL of water
3. Flush the tube before and after administration
4. Consult a pharmacist for specific instructions and potential drug interactions

Potential Risks of Improper Metoprolol Administration

Incorrect administration of metoprolol, particularly crushing extended-release formulations, can lead to serious health risks. Understanding these potential dangers is crucial for both healthcare providers and patients.

Risks of Crushing Metoprolol Succinate

Crushing metoprolol succinate tablets can result in:

• Dose dumping: Rapid release of the entire dose
• Increased risk of side effects
• Potential for toxicity due to high blood levels
• Reduced effectiveness over time

Consequences of Improper Dosing

Improper administration of metoprolol can lead to various health issues:

• Fluctuations in blood pressure
• Irregular heart rate
• Increased risk of cardiovascular events
• Potential for drug interactions

Pharmacokinetics of Metoprolol: Impact of Formulation

The pharmacokinetics of metoprolol – how the drug is absorbed, distributed, metabolized, and eliminated by the body – varies significantly between its two formulations. Understanding these differences is crucial for healthcare providers when prescribing and administering the medication.

Metoprolol Tartrate Pharmacokinetics

Metoprolol tartrate, the immediate-release formulation, has the following pharmacokinetic properties:

• Rapid absorption from the gastrointestinal tract
• Peak plasma concentrations reached within 1-2 hours
• Half-life of approximately 3-4 hours
• Typically dosed twice daily due to shorter duration of action

Metoprolol Succinate Pharmacokinetics

Metoprolol succinate, the extended-release formulation, exhibits different pharmacokinetic characteristics:

• Gradual release of medication over 24 hours
• Steady plasma concentrations maintained throughout the day
• Effective half-life of approximately 24 hours
• Once-daily dosing due to prolonged duration of action

How does the formulation affect metoprolol’s pharmacokinetics? The extended-release formulation of metoprolol succinate allows for more consistent blood levels of the drug over time, potentially leading to better blood pressure control and fewer side effects compared to the immediate-release formulation.

Clinical Implications of Metoprolol Formulations

The choice between metoprolol tartrate and metoprolol succinate has significant clinical implications. Healthcare providers must consider various factors when selecting the appropriate formulation for their patients.

Advantages of Metoprolol Tartrate

• Flexibility in dosing and administration
• Can be crushed for patients with swallowing difficulties
• Rapid onset of action
• May be preferred for acute situations

Benefits of Metoprolol Succinate

• Once-daily dosing improves patient adherence
• More consistent blood levels throughout the day
• May provide better 24-hour blood pressure control
• Potentially fewer side effects due to gradual release

Which formulation of metoprolol is more effective for long-term blood pressure control? While both formulations are effective, metoprolol succinate may provide more consistent 24-hour blood pressure control due to its extended-release properties, potentially leading to better long-term outcomes in hypertension management.

Patient Education: Ensuring Proper Metoprolol Use

Educating patients about the proper use of metoprolol is crucial for ensuring medication safety and efficacy. Healthcare providers play a vital role in conveying this information clearly and effectively.

Key Points for Patient Education

1. Explain the difference between immediate-release and extended-release formulations
2. Emphasize the importance of taking the medication as prescribed
3. Instruct patients never to crush extended-release tablets
4. Advise on proper storage and handling of the medication
5. Discuss potential side effects and when to seek medical attention

Addressing Common Patient Concerns

Healthcare providers should be prepared to address common questions and concerns patients may have about metoprolol:

• Why the medication needs to be taken regularly
• How to handle missed doses
• Potential interactions with other medications or foods
• Long-term effects of the medication
• Options for those who have difficulty swallowing tablets

How can patients ensure they’re taking metoprolol correctly? Patients should always follow their healthcare provider’s instructions, never alter the medication without consulting their doctor, and ask questions if they’re unsure about any aspect of their treatment regimen.

Alternatives to Crushing: Exploring Other Options

When patients have difficulty swallowing metoprolol tablets, particularly the extended-release formulation, healthcare providers must consider alternative approaches to ensure proper medication administration.

Liquid Formulations

While metoprolol itself is not commercially available in liquid form, compounding pharmacies may be able to prepare liquid formulations:

• Custom-made liquid preparations of metoprolol tartrate
• Potential for more precise dosing
• Easier administration for patients with swallowing difficulties
• May have shorter shelf life compared to tablets

Alternative Beta-Blockers

In some cases, switching to a different beta-blocker might be appropriate:

• Atenolol: Available as a scored tablet that can be split
• Propranolol: Comes in liquid form
• Carvedilol: Available as a powder for oral suspension

What factors should be considered when choosing an alternative to metoprolol? When selecting an alternative beta-blocker, healthcare providers must consider the patient’s specific condition, potential side effects, dosing frequency, and the availability of suitable formulations.

The Role of Pharmacists in Metoprolol Administration

Pharmacists play a crucial role in ensuring the safe and effective use of metoprolol. Their expertise is invaluable in addressing administration challenges and providing guidance to both healthcare providers and patients.

Pharmacist Responsibilities

1. Counseling patients on proper medication use
2. Advising healthcare providers on appropriate formulations
3. Preparing alternative formulations when necessary
4. Monitoring for potential drug interactions
5. Providing education on medication storage and handling

Collaborative Care Approach

A collaborative approach between pharmacists, physicians, and other healthcare providers ensures optimal patient care:

• Regular communication about patient needs and concerns
• Joint decision-making on medication adjustments
• Coordinated patient education efforts
• Continuous monitoring of treatment efficacy and safety

How can pharmacists contribute to improving metoprolol therapy outcomes? Pharmacists can significantly improve metoprolol therapy outcomes by providing expert guidance on administration techniques, identifying potential drug interactions, and collaborating with other healthcare providers to tailor treatment plans to individual patient needs.

Future Developments in Metoprolol Formulations

As pharmaceutical technology advances, new formulations of metoprolol and other beta-blockers may emerge, potentially offering improved options for administration and patient care.

Potential Innovations

• Development of orally disintegrating tablets
• Creation of transdermal patch formulations
• Exploration of nasal spray delivery systems
• Research into long-acting injectable formulations

Impact on Patient Care

These potential innovations could significantly impact patient care by:

• Providing easier administration options for patients with swallowing difficulties
• Improving medication adherence through less frequent dosing
• Reducing side effects through alternative delivery methods
• Offering more personalized treatment options

How might future developments in metoprolol formulations affect patient treatment? Future developments in metoprolol formulations could lead to more patient-friendly administration methods, potentially improving treatment adherence and outcomes while reducing the challenges associated with current tablet formulations.

Conclusion

Understanding the proper administration of metoprolol is crucial for ensuring patient safety and treatment efficacy. The stark difference between metoprolol tartrate and metoprolol succinate in terms of crushability highlights the importance of medication-specific knowledge in healthcare settings. While metoprolol tartrate can be safely crushed, metoprolol succinate must never be altered due to its extended-release properties. Healthcare providers, pharmacists, and patients must work together to ensure proper medication use, exploring alternatives when necessary for those with administration challenges. As pharmaceutical technology advances, we may see new formulations that address current limitations, potentially revolutionizing how we approach metoprolol therapy. Ultimately, the goal remains to provide optimal care while prioritizing patient safety and treatment effectiveness.

Can You Crush Metoprolol? | HelloPharmacist

Key points

• There are two different forms of metoprolol available, metoprolol succinate and metoprolol tartrate.
• Metoprolol tartrate can be crushed while metoprolol succinate (an extended-release product) cannot.

Hello and thanks for reaching out!

The answer to this depends on which form of metoprolol you are talking about, as it is available as:

• Metoprolol tartrate
• Metoprolol succinate

Metoprolol tartrate is an immediate-release version of the drug while metoprolol succinate is the extended-release version.

Which Can You Crush?

Metoprolol tartrate (generic for Lopressor) can safely be crushed. Doing so will not alter how the medication works

Metoprolol succinate (generic for Toprol XL) on the other hand, cannot be crushed as it is an extended-release product. Doing so will destroy the extended-release mechanism, causing all of the medication to be released at once.

Interesting enough, metoprolol succinate can be split and is scored (i.e. has a break line in the middle of the tablet). This is uncommon among extended-release drugs and metoprolol succinate is one of the few extended-release drugs where splitting is okay.

Metoprolol succinate can be split due to how the extended-release mechanism works. Each tablet contains contains a number of small controlled release pellets, which are evenly dispersed throughout the tablet. This can be seen in the image below.

Each pellet acts as their own delivery device, and splitting the tablets will not destroy them. For this reason, the tablet can be split. However, as mentioned, the tablets cannot be crushed, as doing so will destroy these pellets.

Final Words

Thanks again for your question!

I hope this answer helped.

Please feel free to reach out to us again in the future.

References

• 
  Metoprolol Monograph,
  PubChem
  
• 
  Toprol XL prescribing Information,
  AccessFDA
  
• 
  Lopressor Prescribing Information,
  AccessFDA
  

To Crush or Not to Crush

There are multiple reasons for crushing tablets or capsule contents before administering medications, but there are numerous medications that should not be crushed. These medications should not be chewed, either, usually due to their specific formulations and their pharmacokinetic properties.1 Most of the no-crush medications are sustained-release, oral-dosage formulas. The majority of extended-release products should not be crushed or chewed, although there are some newer slow-release tablet formulations available that are scored and can be divided or halved (e.g., Toprol XL).

A common reason for crushing a tablet or capsule is for use by a hospitalized patient with an enteral feeding tube. A recent review in the American Journal of Health-System Pharmacy provides more details about administering medications in patients with enteral feeding tubes.2 Oral solutions can be used when commercially available and medically appropriate. If an oral solution or suspension is not available, the hospital pharmacy should be consulted to determine if a liquid formulation of the product can be extemporaneously prepared. In some cases, after careful consideration of compatibility, stability, and drug absorption changes, an injectable formulation of a product may be used. You should always consult your hospital pharmacist for information on this modality of drug administration.

Some patients have difficulty swallowing tablets or capsules; some dislike the taste. In these cases, crushing of medication for powdered delivery (to be mixed with food or beverages) should be considered. But beware of certain caveats, as not all medications are suitable for crushing. Generally, meds that should not be crushed fall into one of these categories:

• Sustained-release tablets, which can be composed of multiple layers for different drug release times, as can beads within capsules. Some of the more common prefixes or suffixes for sustained-release, controlled-release, or controlled-delivery products include: 12-hour, 24-hour, CC, CD, CR, ER, LA, Retard, SA, Slo-, SR, XL, XR, or XT.
• Enteric-coated tablets, which are formulated because certain drugs can be irritating to the stomach or are degraded by stomach acid. By enteric-coating tablets or capsule beads, the drug’s release can be delayed until it reaches the small intestine. Prefixes include EN- and EC-.

Other medications have objectionable tastes and are sugar-coated to improve tolerability. If this type of medication is crushed, the patient would be subject to its unpleasant taste, which could significantly impair medication adherence. Additionally, both sublingual and effervescent medications should not be crushed because it will decrease the medication’s effectiveness.

Hospital Pharmacy publishes a wall chart that includes many of these types of formulations, along with their do’s and don’ts. If there is ever any doubt about the best way to administer a particular product or whether it can be halved or crushed, ask your pharmacist.3 TH

Michele B. Kaufman, PharmD, BSc, RPh, is a freelance medical writer based in New York City.

New Generics

• Stavudine capsules (generic Zerit)4

New Drugs, Indications & Dosage Forms

Cinryze, a C1 esterase inhibitor (human), is FDA-approved as a new orphan drug for routine prophylaxis against angioedema in patients with hereditary angioedema (HAE). 5 The drug is administered intravenously (IV) and can be administered every three to four days for routine HAE attack prevention, which can spontaneously occur during stress, surgery, or infection, and lead to rapid swelling of the hands, feet, limbs, face, intestinal tract, or airway.6

Granisetron 3.1mg/24-hour transdermal patch (Sancuso) is FDA-approved for preventing nausea and vomiting in adults receiving moderate or high-chemotherapy regimens for up to five consecutive days.7 To dose the patch, apply it to a clean, dry area of intact healthy skin on the upper outer arm 24 to 48 hours before chemotherapy, and remove it at least 24 hours after chemotherapy has been completed. A patch may be worn for up to seven days. They should not be cut.

Hydrocodone bitartrate 10-mg/chlorpheniramine 8-mg (Tussicaps) is FDA-approved as a Schedule III controlled substance as an antitussive/antihistamine combination.8 Adult dosage is one capsule every 12 hours.

Lacosamide (Vimpat) is FDA-approved for add-on therapy in patients ≥17 years with uncontrolled, partial-onset seizures. 11 The starting dose is 50 mg twice daily and may be increased to a daily dose of 200-400 mg as two divided doses. The most common adverse reactions in clinical trials were diplopia, headache, dizziness, and nausea. Both the oral tablets and the IV infusion are bioequivalent.

Mesalamine extended-release 0.375-gm capsules (Apriso) is FDA-approved for once-daily dosing for the maintenance of remission of ulcerative colitis.9 Mesalamine is a local-acting aminosalicylate. The recommended dose is four capsules (1.5 g/day) in the morning with or without food. Because release of the active drug is pH-dependent, it should not be administered with antacids.

Ranolazine (Ranexa) is FDA-approved as an initial treatment for chronic angina.10 It can be used as monotherapy, in combination with beta blockers, or with other drugs.

Quetiapine extended-release tablets (Seroquel XR) are FDA-approved to treat depressive episodes in bipolar disorder, manic and mixed episodes in bipolar I disorder, and the maintenance treatment of bipolar I disorder as adjunct therapy to lithium or divalproex.